{"id":3912,"date":"2021-09-27T10:08:42","date_gmt":"2021-09-27T10:08:42","guid":{"rendered":"https:\/\/www.biosafety.kz\/?p=3912"},"modified":"2021-12-28T06:55:13","modified_gmt":"2021-12-28T06:55:13","slug":"%d0%be%d0%bf%d1%83%d0%b1%d0%bb%d0%b8%d0%ba%d0%be%d0%b2%d0%b0%d0%bd%d0%b0-%d0%b2%d1%82%d0%be%d1%80%d0%b0%d1%8f-%d1%81%d1%82%d0%b0%d1%82%d1%8c%d1%8f-%d0%be-%d0%ba%d0%b0%d1%87%d0%b5%d1%81%d1%82%d0%b2","status":"publish","type":"post","link":"https:\/\/biosafety.kz\/en\/uncategorized\/%d0%be%d0%bf%d1%83%d0%b1%d0%bb%d0%b8%d0%ba%d0%be%d0%b2%d0%b0%d0%bd%d0%b0-%d0%b2%d1%82%d0%be%d1%80%d0%b0%d1%8f-%d1%81%d1%82%d0%b0%d1%82%d1%8c%d1%8f-%d0%be-%d0%ba%d0%b0%d1%87%d0%b5%d1%81%d1%82%d0%b2\/","title":{"rendered":"THE SECOND ARTICLE ABOUT THE QUALITY OF THE QazCovid-In (QazVac) VACCINE HAS BEEN PUBLISHED IN AN INTERNATIONAL JOURNAL WITH A HIGH IMPACT FACTOR"},"content":{"rendered":"

Congratulations to the team of authors of RIBSP, developers of the first Kazakh vaccine QazCovid-In (QazVac) with another brilliant publication of the results of scientific research obtained as part of the scientific research project “Development of a vaccine against coronavirus infection COVID-19”.<\/p>\n

The results of preclinical trials of the inactivated vaccine were published by a group of scientists in the authoritative international journal in the field of microbiology “Frontiers in Microbiology”.<\/p>\n

The process of preparing the article was supervised by a young scientist, PhD, head of the laboratory of collection of microorganisms K.D. Zhugunisov.<\/p>\n

In experiments on hamsters, the safety and high protective efficacy of QazCovid-In (QazVac) has been proven on used animals.<\/p>\n

\"\"<\/a><\/p>\n

This publication once again proves the high level of scientific research of the scientists in the field of virology and vaccinology.<\/p>\n

\"\"<\/a><\/p>\n

The results of the colossal work of scientists – the developed vaccine against COVID-19 “QazCovid-in” is a huge achievement of domestic science and an undeniable contribution to ensuring the biological security of the country!<\/p>\n

 ","protected":false},"excerpt":{"rendered":"

Congratulations to the team of authors of RIBSP, developers of the first Kazakh vaccine QazCovid-In (QazVac) with another brilliant publication of the results of scientific research obtained as part of the scientific research project “Development of a vaccine against coronavirus infection COVID-19”. The results of preclinical trials of the inactivated vaccine were published by a […]<\/p>\n","protected":false},"author":1,"featured_media":3919,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/posts\/3912"}],"collection":[{"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/comments?post=3912"}],"version-history":[{"count":14,"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/posts\/3912\/revisions"}],"predecessor-version":[{"id":4092,"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/posts\/3912\/revisions\/4092"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/media\/3919"}],"wp:attachment":[{"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/media?parent=3912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/categories?post=3912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biosafety.kz\/en\/wp-json\/wp\/v2\/tags?post=3912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}